These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 39075210)

  • 1. Guidance for estimating penetrance of monogenic disease-causing variants in population cohorts.
    Wright CF; Sharp LN; Jackson L; Murray A; Ware JS; MacArthur DG; Rehm HL; Patel KA; Weedon MN
    Nat Genet; 2024 Sep; 56(9):1772-1779. PubMed ID: 39075210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced penetrance of MODY-associated HNF1A/HNF4A variants but not GCK variants in clinically unselected cohorts.
    Mirshahi UL; Colclough K; Wright CF; Wood AR; Beaumont RN; Tyrrell J; Laver TW; Stahl R; Golden A; Goehringer JM; ; Frayling TF; Hattersley AT; Carey DJ; Weedon MN; Patel KA
    Am J Hum Genet; 2022 Nov; 109(11):2018-2028. PubMed ID: 36257325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.
    Cooper DN; Krawczak M; Polychronakos C; Tyler-Smith C; Kehrer-Sawatzki H
    Hum Genet; 2013 Oct; 132(10):1077-130. PubMed ID: 23820649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian approach to determining penetrance of pathogenic SDH variants.
    Benn DE; Zhu Y; Andrews KA; Wilding M; Duncan EL; Dwight T; Tothill RW; Burgess J; Crook A; Gill AJ; Hicks RJ; Kim E; Luxford C; Marfan H; Richardson AL; Robinson B; Schlosberg A; Susman R; Tacon L; Trainer A; Tucker K; Maher ER; Field M; Clifton-Bligh RJ
    J Med Genet; 2018 Nov; 55(11):729-734. PubMed ID: 30201732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Autopsy of Sudden Deaths in Young Individuals.
    Webster G; Puckelwartz MJ; Pesce LL; Dellefave-Castillo LM; Vanoye CG; Potet F; Page P; Kearns SD; Pottinger T; White S; Arunkumar P; Olson R; Kofman A; Ibrahim N; Ing A; Brew C; Yap KL; Kadri S; George AL; McNally EM
    JAMA Cardiol; 2021 Nov; 6(11):1247-1256. PubMed ID: 34379075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of penetrance and variable expressivity in monogenic metabolic conditions across 77,184 exomes.
    Goodrich JK; Singer-Berk M; Son R; Sveden A; Wood J; England E; Cole JB; Weisburd B; Watts N; Caulkins L; Dornbos P; Koesterer R; Zappala Z; Zhang H; Maloney KA; Dahl A; Aguilar-Salinas CA; Atzmon G; Barajas-Olmos F; Barzilai N; Blangero J; Boerwinkle E; Bonnycastle LL; Bottinger E; Bowden DW; Centeno-Cruz F; Chambers JC; Chami N; Chan E; Chan J; Cheng CY; Cho YS; Contreras-Cubas C; Córdova E; Correa A; DeFronzo RA; Duggirala R; Dupuis J; Garay-Sevilla ME; García-Ortiz H; Gieger C; Glaser B; González-Villalpando C; Gonzalez ME; Grarup N; Groop L; Gross M; Haiman C; Han S; Hanis CL; Hansen T; Heard-Costa NL; Henderson BE; Hernandez JMM; Hwang MY; Islas-Andrade S; Jørgensen ME; Kang HM; Kim BJ; Kim YJ; Koistinen HA; Kooner JS; Kuusisto J; Kwak SH; Laakso M; Lange L; Lee JY; Lee J; Lehman DM; Linneberg A; Liu J; Loos RJF; Lyssenko V; Ma RCW; Martínez-Hernández A; Meigs JB; Meitinger T; Mendoza-Caamal E; Mohlke KL; Morris AD; Morrison AC; Ng MCY; Nilsson PM; O'Donnell CJ; Orozco L; Palmer CNA; Park KS; Post WS; Pedersen O; Preuss M; Psaty BM; Reiner AP; Revilla-Monsalve C; Rich SS; Rotter JI; Saleheen D; Schurmann C; Sim X; Sladek R; Small KS; So WY; Spector TD; Strauch K; Strom TM; Tai ES; Tam CHT; Teo YY; Thameem F; Tomlinson B; Tracy RP; Tuomi T; Tuomilehto J; Tusié-Luna T; van Dam RM; Vasan RS; Wilson JG; Witte DR; Wong TY; ; Burtt NP; Zaitlen N; McCarthy MI; Boehnke M; Pollin TI; Flannick J; Mercader JM; O'Donnell-Luria A; Baxter S; Florez JC; MacArthur DG; Udler MS
    Nat Commun; 2021 Jun; 12(1):3505. PubMed ID: 34108472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts.
    Kingdom R; Wright CF
    Front Genet; 2022; 13():920390. PubMed ID: 35983412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clustering of predicted loss-of-function variants in genes linked with monogenic disease can explain incomplete penetrance.
    Beaumont RN; Hawkes G; Gunning AC; Wright CF
    Genome Med; 2024 Apr; 16(1):64. PubMed ID: 38671509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the ExAC data set for the presence of individuals with pathogenic genotypes implicated in severe Mendelian pediatric disorders.
    Tarailo-Graovac M; Zhu JYA; Matthews A; van Karnebeek CDM; Wasserman WW
    Genet Med; 2017 Dec; 19(12):1300-1308. PubMed ID: 28471432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
    Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
    JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence estimation for monogenic autosomal recessive diseases using population-based genetic data.
    Schrodi SJ; DeBarber A; He M; Ye Z; Peissig P; Van Wormer JJ; Haws R; Brilliant MH; Steiner RD
    Hum Genet; 2015 Jun; 134(6):659-69. PubMed ID: 25893794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the Pathogenicity, Penetrance, and Expressivity of Putative Disease-Causing Variants in a Population Setting.
    Wright CF; West B; Tuke M; Jones SE; Patel K; Laver TW; Beaumont RN; Tyrrell J; Wood AR; Frayling TM; Hattersley AT; Weedon MN
    Am J Hum Genet; 2019 Feb; 104(2):275-286. PubMed ID: 30665703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low coverage whole genome sequencing enables accurate assessment of common variants and calculation of genome-wide polygenic scores.
    Homburger JR; Neben CL; Mishne G; Zhou AY; Kathiresan S; Khera AV
    Genome Med; 2019 Nov; 11(1):74. PubMed ID: 31771638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of Adenosine Deaminase 2 (DADA2): Hidden Variants, Reduced Penetrance, and Unusual Inheritance.
    Schnappauf O; Zhou Q; Moura NS; Ombrello AK; Michael DG; Deuitch N; Barron K; Stone DL; Hoffmann P; Hershfield M; Applegate C; Bjornsson HT; Beck DB; Witmer PD; Sobreira N; Wohler E; Chiorini JA; Center TAG; Dalgard CL; Center NIS; Kastner DL; Aksentijevich I
    J Clin Immunol; 2020 Aug; 40(6):917-926. PubMed ID: 32638197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-Based Penetrance of Deleterious Clinical Variants.
    Forrest IS; Chaudhary K; Vy HMT; Petrazzini BO; Bafna S; Jordan DM; Rocheleau G; Loos RJF; Nadkarni GN; Cho JH; Do R
    JAMA; 2022 Jan; 327(4):350-359. PubMed ID: 35076666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting Causal Variants in Mendelian Disorders Using Whole-Genome Sequencing.
    Hamzeh AR; Andrews TD; Field MA
    Methods Mol Biol; 2021; 2243():1-25. PubMed ID: 33606250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Prevalence of Deleterious
    LeDoux MS
    Tremor Other Hyperkinet Mov (N Y); 2020 Nov; 10():50. PubMed ID: 33200041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the penetrance of pathogenic gene variants in families with missing pedigree information.
    Jonker MA; Rijken JA; Hes FJ; Putter H; Hensen EF
    Stat Methods Med Res; 2019; 28(10-11):2924-2936. PubMed ID: 30073909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test.
    Lionel AC; Costain G; Monfared N; Walker S; Reuter MS; Hosseini SM; Thiruvahindrapuram B; Merico D; Jobling R; Nalpathamkalam T; Pellecchia G; Sung WWL; Wang Z; Bikangaga P; Boelman C; Carter MT; Cordeiro D; Cytrynbaum C; Dell SD; Dhir P; Dowling JJ; Heon E; Hewson S; Hiraki L; Inbar-Feigenberg M; Klatt R; Kronick J; Laxer RM; Licht C; MacDonald H; Mercimek-Andrews S; Mendoza-Londono R; Piscione T; Schneider R; Schulze A; Silverman E; Siriwardena K; Snead OC; Sondheimer N; Sutherland J; Vincent A; Wasserman JD; Weksberg R; Shuman C; Carew C; Szego MJ; Hayeems RZ; Basran R; Stavropoulos DJ; Ray PN; Bowdin S; Meyn MS; Cohn RD; Scherer SW; Marshall CR
    Genet Med; 2018 Apr; 20(4):435-443. PubMed ID: 28771251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calculating variant penetrance from family history of disease and average family size in population-scale data.
    Spargo TP; Opie-Martin S; Bowles H; Lewis CM; Iacoangeli A; Al-Chalabi A
    Genome Med; 2022 Dec; 14(1):141. PubMed ID: 36522764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.